ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $505k

      Shares

      2.56k

      % of Portfolio

      0.00%

      Average Buy Price

      $72.9

      Avg closing price
      Price range

      21 Polen Capital Houlihan Lokey Trades

      Polen Capital acquired 2.56k Houlihan Lokey shares worth $505k. That's 0.00% of their equity portfolio (194th largest holding). The first Houlihan Lokey trade was made in Q2 2020. Since then Polen Capital bought shares seven more times and sold shares on thirteen occasions. The stake costed the investor $186k, netting the investor a gain of 171% so far.

      Avg closing price
      Price range
      Sold 92.1% shares (-29.7k shares) Q2 2025
      Avg closing price $167.92
      Price range $141.59 - $182.75
      Sold 10.3% shares (-3.7k shares) Q1 2025
      Avg closing price $172.03
      Price range $154.43 - $187.40
      Sold 47.3% shares (-32.3k shares) Q4 2024
      Avg closing price $176.28
      Price range $158.81 - $190.49
      Sold 17.1% shares (-14.1k shares) Q3 2024
      Avg closing price $149.27
      Price range $134.11 - $161.98
      Sold 8.5% shares (-7.65k shares) Q2 2024
      Avg closing price $130.89
      Price range $122.38 - $136.80
      Sold 29.3% shares (-37.3k shares) Q1 2024
      Avg closing price $123.71
      Price range $114.14 - $131.85
      Sold 1.3% shares (-1.67k shares) Q4 2023
      Avg closing price $108.42
      Price range $96.94 - $122.19
      Sold 1.5% shares (-1.93k shares) Q3 2023
      Avg closing price $103.11
      Price range $94.84 - $110.06
      Sold 4.9% shares (-6.69k shares) Q2 2023
      Avg closing price $90.45
      Price range $84.95 - $98.88
      Sold 2.6% shares (-3.68k shares) Q1 2023
      Avg closing price $94.09
      Price range $85.36 - $100.78
      Sold 11.8% shares (-18.8k shares) Q4 2022
      Avg closing price $89.89
      Price range $76.69 - $101.58
      Increased shares by 9.6% (+14k shares) Q3 2022
      Avg closing price $81.03
      Price range $75.03 - $88.87
      Sold 16.4% shares (-28.6k shares) Q2 2022
      Avg closing price $83.61
      Price range $76.53 - $89.40
      Sold 4.1% shares (-7.52k shares) Q1 2022
      Avg closing price $102.96
      Price range $87.80 - $119.53
      Increased shares by 25.3% (+36.7k shares) Q4 2021
      Avg closing price $106.77
      Price range $93.45 - $118.96
      Increased shares by 8.0% (+10.7k shares) Q3 2021
      Avg closing price $87.64
      Price range $80.26 - $95.55
      Increased shares by 6.7% (+8.4k shares) Q2 2021
      Avg closing price $72.40
      Price range $65.35 - $81.79
      Increased shares by 21.0% (+21.9k shares) Q1 2021
      Avg closing price $67.48
      Price range $63.56 - $72.24
      Increased shares by 32.2% (+25.4k shares) Q4 2020
      Avg closing price $64.82
      Price range $59.42 - $70.10
      Increased shares by 76.6% (+34.2k shares) Q3 2020
      Avg closing price $57.31
      Price range $54.55 - $60.34

      News about Houlihan Lokey Inc - Ordinary Shares - Class A and Polen Capital

      Houlihan Lokey, Inc.: Houlihan Lokey Expands Capital Markets Team With Senior European Hire

      Houlihan Lokey, Inc.: Houlihan Lokey Expands Capital Markets Team With Senior European Hire

      Vieri Betti Guaraldi Joins as a Managing Director in Milan Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Vieri Betti Guar...

      Finanz Nachrichten Finanz Nachrichten, over 1 year ago
      Houlihan Lokey Expands Capital Markets Team With Senior European Hire

      Houlihan Lokey Expands Capital Markets Team With Senior European Hire

      MILAN--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Vieri Betti Guaraldi has joined as a Managing Direc...

      businesswire.com businesswire.com, over 1 year ago
      IQ-AI boosted with second FDA rare pediatric disease designation for GaM

      IQ-AI boosted with second FDA rare pediatric disease designation for GaM

      IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) told investors that its subsidiary, Imaging Biometrics, has received a second US FDA Rare Pediatric Disease Designation (RP...

      https://www.proactiveinvestors.com https://www.proactiveinvestors.com, over 1 year ago
      Chariot kicks off OBA well drilling

      Chariot kicks off OBA well drilling

      Chariot Ltd (AIM:CHAR, OTC:OIGLF) told investors it has started drilling the OBA-1 well, on the Dartois prospect located in the Loukos Onshore licence, in Mo...

      https://www.proactiveinvestors.com https://www.proactiveinvestors.com, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×